AU758299B2 - Multiparticulate pharmaceutical form with programmed and timed release and preparation method - Google Patents

Multiparticulate pharmaceutical form with programmed and timed release and preparation method Download PDF

Info

Publication number
AU758299B2
AU758299B2 AU38302/99A AU3830299A AU758299B2 AU 758299 B2 AU758299 B2 AU 758299B2 AU 38302/99 A AU38302/99 A AU 38302/99A AU 3830299 A AU3830299 A AU 3830299A AU 758299 B2 AU758299 B2 AU 758299B2
Authority
AU
Australia
Prior art keywords
pharmaceutical form
coating
form according
polymer
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU38302/99A
Other languages
English (en)
Other versions
AU3830299A (en
Inventor
Marie-Christine Clee-Bouvet
Gerard Cousin
Edouard Gendrot
Francoise Ragot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Laboratories Prographarm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Prographarm SA filed Critical Laboratories Prographarm SA
Publication of AU3830299A publication Critical patent/AU3830299A/en
Application granted granted Critical
Publication of AU758299B2 publication Critical patent/AU758299B2/en
Assigned to ETHYPHARM reassignment ETHYPHARM Alteration of Name(s) of Applicant(s) under S113 Assignors: LABORATOIRES PROGRAPHARM
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38302/99A 1998-05-20 1999-05-20 Multiparticulate pharmaceutical form with programmed and timed release and preparation method Expired AU758299B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR98/06384 1998-05-20
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (2)

Publication Number Publication Date
AU3830299A AU3830299A (en) 1999-12-06
AU758299B2 true AU758299B2 (en) 2003-03-20

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38302/99A Expired AU758299B2 (en) 1998-05-20 1999-05-20 Multiparticulate pharmaceutical form with programmed and timed release and preparation method

Country Status (24)

Country Link
EP (1) EP1077687B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002515423A (cg-RX-API-DMAC7.html)
KR (1) KR100583065B1 (cg-RX-API-DMAC7.html)
CN (1) CN1186014C (cg-RX-API-DMAC7.html)
AT (1) ATE214598T1 (cg-RX-API-DMAC7.html)
AU (1) AU758299B2 (cg-RX-API-DMAC7.html)
BG (1) BG64764B1 (cg-RX-API-DMAC7.html)
BR (1) BR9910606A (cg-RX-API-DMAC7.html)
CA (1) CA2333188C (cg-RX-API-DMAC7.html)
DE (1) DE69901062T2 (cg-RX-API-DMAC7.html)
DK (1) DK1077687T3 (cg-RX-API-DMAC7.html)
ES (1) ES2173739T3 (cg-RX-API-DMAC7.html)
FR (1) FR2778848B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20022750B (cg-RX-API-DMAC7.html)
HU (1) HU224193B1 (cg-RX-API-DMAC7.html)
IL (1) IL139774A (cg-RX-API-DMAC7.html)
MX (1) MXPA00011364A (cg-RX-API-DMAC7.html)
NO (1) NO330501B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ508392A (cg-RX-API-DMAC7.html)
PL (1) PL192950B1 (cg-RX-API-DMAC7.html)
PT (1) PT1077687E (cg-RX-API-DMAC7.html)
TR (1) TR200100107T2 (cg-RX-API-DMAC7.html)
WO (1) WO1999059557A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200006768B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
US10111832B2 (en) 2012-12-17 2018-10-30 Ethypharm Orodispersible tablets obtained by compression molding

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
WO2006047493A2 (en) 2004-10-21 2006-05-04 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017261A1 (fr) * 1996-10-22 1998-04-30 Laboratoires Prographarm Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017261A1 (fr) * 1996-10-22 1998-04-30 Laboratoires Prographarm Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
US10111832B2 (en) 2012-12-17 2018-10-30 Ethypharm Orodispersible tablets obtained by compression molding

Also Published As

Publication number Publication date
IL139774A0 (en) 2002-02-10
NO20005838L (no) 2001-01-10
MXPA00011364A (es) 2008-09-09
CN1186014C (zh) 2005-01-26
JP2002515423A (ja) 2002-05-28
PL192950B1 (pl) 2006-12-29
HUP0102027A2 (hu) 2002-03-28
NZ508392A (en) 2002-09-27
EP1077687A1 (fr) 2001-02-28
DE69901062D1 (de) 2002-04-25
AU3830299A (en) 1999-12-06
ZA200006768B (en) 2001-11-20
BG104963A (en) 2001-07-31
KR20010052370A (ko) 2001-06-25
DE69901062T2 (de) 2002-10-31
ATE214598T1 (de) 2002-04-15
BG64764B1 (bg) 2006-03-31
NO330501B1 (no) 2011-05-02
FR2778848B1 (fr) 2001-11-23
DK1077687T3 (da) 2002-06-17
WO1999059557A1 (fr) 1999-11-25
CN1305371A (zh) 2001-07-25
HUP0102027A3 (en) 2002-12-28
PT1077687E (pt) 2002-09-30
TR200100107T2 (tr) 2001-06-21
NO20005838D0 (no) 2000-11-17
KR100583065B1 (ko) 2006-06-08
GEP20022750B (en) 2002-08-26
CA2333188C (fr) 2010-07-06
ES2173739T3 (es) 2002-10-16
CA2333188A1 (fr) 1999-11-25
PL344314A1 (en) 2001-10-22
EP1077687B1 (fr) 2002-03-20
HK1033271A1 (en) 2001-08-24
FR2778848A1 (fr) 1999-11-26
HU224193B1 (hu) 2005-06-28
BR9910606A (pt) 2001-10-02
IL139774A (en) 2005-09-25

Similar Documents

Publication Publication Date Title
US6039979A (en) Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation
KR100221695B1 (ko) 약학적 구상 제형
US4784858A (en) Controlled release tablet
EP2034974B1 (en) Lipoic acid pellets
KR960013434B1 (ko) 서방성 제제
US20130330404A1 (en) Extended release composition containing tramadol
PT642335E (pt) Preparacao de um sal de morfina de libertacao controlada
CA2388560A1 (en) Sustained-release form of administration containing tramadol saccharinate
AU3830299A (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
JP2003502360A (ja) トラマドールとジクロフェナクの固定組合せ物を投与するための経口投与形
JP2002541107A (ja) トルペリソンを含有する経口投与のための薬学的製剤
US6310089B1 (en) Composition for the administration of a D1-agonists
JP2002537323A (ja) ロラタジン及びプソイドエフェドリンを含有する医薬カプセル組成物
AU2004255504A1 (en) Novel solid pharmaceutical composition comprising amisulpride
KR0133531B1 (ko) 액체 약제 제형용 서방성 치료 시스템
JP2003534372A (ja) 呼吸機能低下と闘うための薬剤
KR100605370B1 (ko) 슈도에페드린 또는 그의 염의 방출제어형 약제학적 조성물
HK1033271B (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method
KR20060069016A (ko) 슈도에페드린 또는 그의 염의 방출제어형 약제학적 조성물

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: ETHYPHARM

Free format text: THE FORMER OWNER WAS: LABORATOIRES PROGRAPHARM

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired